Physician profile
John Sherman Bruner
NPI 1194821249
$81,504.68
in general payments reported to CMS, 2019-2025
21 companies · $30K in 2025
The $30K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46.31 · 2020: $44.30 · 2021: $6,437 · 2022: $189 · 2023: $4,624 · 2024: $40K · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $68K · Food and Beverage: $4,411 · Travel and Lodging: $2,291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $68,085.95 |
| Food and Beverage | $4,411.17 |
| Travel and Lodging | $2,290.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $80,374.53 | 2021-2025 | Da Vinci Surgical System |
| Shield Therapeutics INC | $247.31 | 2024-2025 | |
| Abbvie INC. | $128.06 | 2019-2022 | |
| Astellas Pharma US INC | $115.68 | 2023-2025 | Veozah |
| Organon LLC | $113.42 | 2022-2025 | Nexplanon |
| Pfizer INC. | $70.76 | 2019-2024 | |
| Biohaven Pharmaceuticals, INC. | $57.70 | 2021 | |
| Mayne Pharma Commercial LLC | $56.50 | 2022-2025 | |
| Agile Therapeutics, INC. | $55.77 | 2021-2023 | Twirla |
| Bayer Healthcare Pharmaceuticals INC. | $41.61 | 2019-2025 | |
| Therapeuticsmd, INC. | $40.89 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $37.80 | 2022 | |
| Sanofi Pasteur INC. | $28.39 | 2024 | |
| Sumitomo Pharma America, INC. | $28.25 | 2023-2024 | Myfembree, Gemtesa |
| Biogen, INC. | $21.35 | 2025 | Zurzuvae |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $17.12 | 2023 | Aptima |
| Boston Scientific Corporation | $14.37 | 2023 | Upsylon |
| Avanos Medical | $14.25 | 2023 | On-Q* Pump and Accessories |
| Avion Pharmaceuticals | $13.96 | 2021 | |
| Merck Sharp & Dohme LLC | $13.75 | 2020 | |
| Exeltis, USA INC. | $13.21 | 2023 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bruner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.